The US is reconsidering its bird flu strategy, potentially moving towards vaccination after years of culling infected flocks. The USDA has conditionally licenced a vaccine but is yet to approve widespread use. While vaccines could help control outbreaks, trade restrictions and concerns about virus mutations present challenges. Experts are evaluating risks, economic impact and alternative vaccination methods.